The effect of budesonide particle mass on drug particle detachment from carrier crystals in adhesive mixtures during inhalation

被引:21
作者
Dickhoff, BHJ
Ellison, MJH
de Boer, AH
Frijlink, HW
机构
[1] Univ Groningen, Dept Pharmaceut Technol & Biopharm, GUIDE, NL-9713 AV Groningen, Netherlands
[2] DMV Int, Veghel, Netherlands
关键词
dry powder inhalation; adhesive mixtures; drug particle size; drug particle detachment; budesonide; fine particle fraction;
D O I
10.1016/S0939-6411(02)00082-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The different fine particle fractions (FPFs) that are obtained, when different dry powder inhalers (DPIs) are used for the same powder formulation at the same flow rate, is the result of different powder de-agglomeration efficiencies for these DPIs. For adhesive mixtures, this is the efficiency with which the kinetic energy of the air flow through the DPI is converted into separation forces that detach drug particles from carrier crystals. We investigated the effect of drug particle diameter (mass) on drug-carrier separation during inhalation with three different inhalers (Sofotec Novolizer, Inhalator Ingelheim and a special test inhaler), at two different flow rates (30 and 601/min). Two different size fractions were used as carrier material (45-63 and 100-150 mum). We measured decreasing amounts of residual drug on the carrier crystals after inhalation with increasing drug particle mass for all inhalers at both flow rates. The observed trends were the same for both carrier fractions. The decrease in residual drug on carrier is in agreement with increasing FPFs in an Erweka impactor. However, it has been calculated that the magnitude of the effect decreases with increasing de-agglomeration efficiency. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:245 / 248
页数:4
相关论文
共 6 条
[1]  
de Boer A. H., 1997, European Respiratory Journal Supplement, V10, p236S
[2]  
Hickey A.J., 1994, Pharm. Technol, V18, P58
[3]  
Hinds WC, 1982, AEROSOL TECHNOLOGY P
[4]   Effect of surface morphology of carrier lactose on dry powder inhalation property of pranlukast hydrate [J].
Kawashima, Y ;
Serigano, T ;
Hino, T ;
Yamamoto, H ;
Takeuchi, H .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 172 (1-2) :179-188
[5]   Adhesion forces in interactive powder mixtures of a micronized drug and carrier particles of various particle size distributions [J].
Podczeck, F .
JOURNAL OF ADHESION SCIENCE AND TECHNOLOGY, 1998, 12 (12) :1323-1339
[6]  
STANIFORTH JN, 1996, Patent No. 9623485